{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:45:59Z","timestamp":1760852759032},"reference-count":19,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":353,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1034\/j.1600-0404.2001.00119.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T02:26:13Z","timestamp":1047349573000},"page":"2-6","source":"Crossref","is-referenced-by-count":1,"title":["High <sup>3<\/sup>\nH-vesamicol binding in ALS motor neurons - autoradiographic visualization of hyperactivity?"],"prefix":"10.1155","volume":"103","author":[{"given":"E.","family":"Grundstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P-G.","family":"Gillberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-M.","family":"Aquilonius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB1|cit2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mus.880100603","article-title":"Recent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies","volume":"10","author":"Bradley","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB2|cit3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0022-510X(94)90170-8","article-title":"Excitotoxicity and motor neurone disease: a review of the evidence","volume":"124","author":"Shaw","year":"1994","journal-title":"Neurol Sci"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB3|cit4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.410400307","article-title":"Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons","volume":"40","author":"Mu","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB4|cit5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0404.1999.tb00403.x","article-title":"Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons","volume":"100","author":"Ekegren","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB5|cit6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0022-510x(98)00333-5","article-title":"Increased expression of glial cell line-derived neurotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosis","volume":"162","author":"Grundstr\u00f6m","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB6|cit7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1073\/pnas.84.3.876","article-title":"Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183)","volume":"84","author":"Marien","year":"1987","journal-title":"Proc Natl Acad Sci"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB7|cit8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/s0197-4580(97)00038-9","article-title":"Vesicular acetylcholine transporter density and Alzheimer's disease","volume":"18","author":"Efange","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB8|cit9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/s0014-2999(97)81946-2","article-title":"Vesamicol and some of its derivatives: Questionable ligands for selectivity labelling acetylcholine transporters in rat brain","volume":"338","author":"Custers","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB9|cit10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-2999(91)90318-K","article-title":"Alpha-adrenoceptor blocking properties of vesamicol","volume":"201","author":"Wannan","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB10|cit11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0404.1985.tb00874.x","article-title":"Cholinergic, opioid and glycine receptor binding sites localized in human spinal cord by in vitro autoradiography. Changes in amyotrophic lateral sclerosis","volume":"72","author":"Gillberg","year":"1985","journal-title":"Acta Neurol Scand"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB11|cit12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial \u201cClinical limits of amyotrophic lateral sclerosis\u201d workshop contributors","volume":"124","author":"Brooks","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB12|cit13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1523\/JNEUROSCI.02-08-01129.1982","article-title":"Light microscopic localization of brain opiate receptors: a general autoradiographic method which preserves tissue quality","volume":"2","author":"Herkenham","year":"1982","journal-title":"J Neurosci"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB13|cit14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0006-8993(84)90843-6","article-title":"Muscarinic binding sites in small homogenates and in autoradiographic sections from rat and human spinal cord","volume":"300","author":"Gillberg","year":"1984","journal-title":"Brain Res"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB14|cit15","first-page":"114","article-title":"Cholinergic markers in ALS spinal cord","volume":"108","author":"Berger","year":"1992","journal-title":"J Neurosci"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB15|cit16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-8993(82)90439-5","article-title":"Choline acetyltransferase and substance P-like immuno-reactivity in the human spinal cord: changes in amyotrophic lateral sclerosis","volume":"250","author":"Gillberg","year":"1982","journal-title":"Brain Res"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB16|cit17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(82)90081-6","article-title":"Regional distribution of cholinergic neurons in human spinal cord transections in the patients with and without motor neuron disease","volume":"244","author":"Nagata","year":"1982","journal-title":"Brain Res"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB17|cit18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410280106","article-title":"Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis","volume":"28","author":"Rothstein","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB18|cit19","doi-asserted-by":"crossref","unstructured":"Kish SJ Distefano LM Dosic S et\u00a0al [ 3 H]Vesamicol binding in human brain cholinergic deficiency disorders Neurosci Lett 1990 347 52","DOI":"10.1016\/0304-3940(90)90689-7"},{"key":"10.1034\/j.1600-0404.2001.00119.x-BIB19|cit20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0306-4522(90)90086-J","article-title":"Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson\u2019s disease, and rats with basal forebrain lesion","volume":"35","author":"Ruberg","year":"1990","journal-title":"Neurosci"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0404.2001.00119.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0404.2001.00119.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1600-0404.2001.00119.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:43:11Z","timestamp":1671540191000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1034\/j.1600-0404.2001.00119.x"}},"subtitle":["<sup>3<\/sup>\nH-vesamicol binding in ALS spinal cord motor neurons"],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"URL":"https:\/\/doi.org\/10.1034\/j.1600-0404.2001.00119.x","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}